{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T08:15:14Z","timestamp":1792743314808,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.ejmech.2013.12.014","type":"journal-article","created":{"date-parts":[[2013,12,25]],"date-time":"2013-12-25T14:45:45Z","timestamp":1387982745000},"page":"217-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Design, synthesis and evaluation of the antidepressant and anticonvulsant activities of triazole-containing quinolinones"],"prefix":"10.1016","volume":"73","author":[{"given":"Xian-Qing","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Xia","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe-Shan","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2013.12.014_bib1","series-title":"Goodman & Gilman's the Phamacological Basis of Therapeutics","first-page":"583","article-title":"Pharmacotherapy of the epilepsies","author":"McNamara","year":"2011"},{"key":"10.1016\/j.ejmech.2013.12.014_bib2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/ebmh.7.4.123","article-title":"Depressive disorders were the fourth leading cause of global disease burden in the year 2000","volume":"7","author":"Meyer","year":"2004","journal-title":"Evid. Based Ment. Health"},{"key":"10.1016\/j.ejmech.2013.12.014_bib3","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1046\/j.1528-1157.44.s4.4.x","article-title":"The recognition and management of mood disorders as a co morbidity of epilepsy","volume":"44","author":"Barry","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejmech.2013.12.014_bib4","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1212\/WNL.58.8_suppl_5.S27","article-title":"Depression and epilepsy. How closely related are they?","volume":"58","author":"Kanner","year":"2002","journal-title":"Neurology"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.ejmech.2013.12.014_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1528-1157.2002.043s2014.x","article-title":"Antidepressant drugs: indications and guidelines for use in epilepsy","volume":"43","author":"Schmitz","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejmech.2013.12.014_bib6","doi-asserted-by":"crossref","first-page":"i45","DOI":"10.1136\/jnnp.2004.060467","article-title":"Depression and anxiety in epileosy","volume":"76","author":"Jackson","year":"2005","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.ejmech.2013.12.014_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1535-7597.2005.05106.x","article-title":"Depression in epilepsy: a neurobiologic perspective","volume":"5","author":"Kanner","year":"2005","journal-title":"Epilepsy Curr."},{"key":"10.1016\/j.ejmech.2013.12.014_bib8","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1212\/WNL.33.5.646","article-title":"Effect of doxepin on seizure frequency in depressed epileptic patients","volume":"33","author":"Ojemann","year":"1982","journal-title":"Neurology"},{"key":"10.1016\/j.ejmech.2013.12.014_bib9","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1212\/WNL.45.10.1926","article-title":"Anticonvulsant effect of fluoxetine in humans","volume":"45","author":"Favale","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.ejmech.2013.12.014_bib10","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.5012\/bkcs.2005.26.11.1757","article-title":"Synthesis of 6-alkyloxyl-3,4-dihydro-2(1H)-quinoliones and their anticonvulsant activities","volume":"26","author":"Quan","year":"2005","journal-title":"Bull. Korean Chem. Soc."},{"key":"10.1016\/j.ejmech.2013.12.014_bib11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.5012\/bkcs.2010.31.02.447","article-title":"Synthesis and studies on anticonvulsant and antidepressant activities of 5-alkoxy-tetrazolo[1,5-a]quinolines","volume":"31","author":"Deng","year":"2010","journal-title":"Bull. Korean Chem. Soc."},{"key":"10.1016\/j.ejmech.2013.12.014_bib12","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.2174\/138955709791012247","article-title":"Biological activities of quinoline derivatives","volume":"9","author":"Kumar","year":"2009","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.12.014_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejphar.2012.06.004","article-title":"Anti-cancer activity and mutagenic potential of novel copper (II) quinolinone Schiff base complexes in hepatocarcinoma cells","volume":"689","author":"Duff","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2013.12.014_bib14","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1016\/j.bmc.2012.05.035","article-title":"Synthesis of 6-substituted 9-methoxy-11H-indeno[1,2-c]quinoline-11-one derivatives as potential anticancer agents","volume":"20","author":"Tseng","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.12.014_bib15","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00706-011-0692-2","article-title":"Synthesis and biological studies of some new acrylic acid ethyl esters of quinolinone","volume":"143","author":"Kalkhambkar","year":"2012","journal-title":"Monatsh. Chem."},{"key":"10.1016\/j.ejmech.2013.12.014_bib16","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00706-011-0608-1","article-title":"Solvent-free synthesis and antibacterial studies of some quinolinones","volume":"143","author":"Subashini","year":"2012","journal-title":"Monatsh. Chem."},{"key":"10.1016\/j.ejmech.2013.12.014_bib17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ejmech.2012.12.034","article-title":"Synthesis and evaluation of antibacterial activity of 7-alkyloxy-4,5-dihydro-imidazo[1,2-a]quinoline derivatives","volume":"60","author":"Sun","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.12.014_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/157018013804142375","article-title":"Design, synthesis and evaluation of novel 2-piperidinyl quinoline chalcones\/amines as potential antidepressant agents","volume":"10","author":"Obaid","year":"2013","journal-title":"Lett. Drug Design Discov."},{"key":"10.1016\/j.ejmech.2013.12.014_bib19","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1007\/s00044-011-9922-8","article-title":"Synthesis and study of the antidepressant activity of novel 4,5-dihydro-7-alkoxy(phenoxy)-tetrazolo[1,5-a]quinoline derivatives","volume":"21","author":"Sun","year":"2012","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2013.12.014_bib20","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.ejmech.2010.12.002","article-title":"Synthesis, antidepressant and antifungal evaluation of novel 2-chloro-8-methylquinoline amine derivatives","volume":"46","author":"Kumar","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.12.014_bib21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1021\/jm980333v","article-title":"3,4-dihydro-2(1H)-quinolinone as a novel antidepressant drug: synthesis and pharmacology of 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-3,4-dihydro-5-methoxy-2(1H)-quinolinone and its derivatives","volume":"43","author":"Oshiro","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.12.014_bib22","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1124\/dmd.108.020545","article-title":"Comparison of the bioactivation potential of the antidepressant and hepatotoxin nefazodone with aripiprazole, a structural analog and marketed drug","volume":"36","author":"Bauman","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejmech.2013.12.014_bib23","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2165\/00023210-200822100-00002","article-title":"Aripiprazole \u2013 in major depressive disorder","volume":"22","author":"Weber","year":"2008","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejmech.2013.12.014_bib24","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejmech.2012.11.042","article-title":"Antidepressant and antipsychotic activity of new quinoline- and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HT1A\/5-HT2A\/5-HT7 and dopamine D-2\/D-3 receptors","volume":"60","author":"Zajdel","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.12.014_bib25","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pnpbp.2012.07.008","article-title":"Comparison of the efficacy between paroxetine and sertraline augmented with aripiprazole in patients with refractory major depressive disorder","volume":"39","author":"Yoshimura","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.ejmech.2013.12.014_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/S0924-977X(12)70457-1","article-title":"Efficacy and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder","volume":"22","author":"Shin","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ejmech.2013.12.014_bib27","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2147\/NDT.S18333","article-title":"Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder","volume":"7","author":"Berman","year":"2011","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.ejmech.2013.12.014_bib28","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1016\/j.ejmech.2009.06.031","article-title":"Synthesis and antimicrobial activities of novel quinoline derivatives carrying 1,2,4-triazole moiety","volume":"44","author":"Eswaran","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.12.014_bib29","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1016\/j.ejmech.2009.05.022","article-title":"Synthesis of some new 1,2,4-triazoles starting from isonicotinic acid hydrazide and evaluation of their antimicrobial activities","volume":"44","author":"Bayrak","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.12.014_bib30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2174\/157018009787847846","article-title":"Synthesis and biological evaluation of aromatase inhibitors","volume":"6","author":"Zhou","year":"2009","journal-title":"Lett. Drug Design Discov."},{"key":"10.1016\/j.ejmech.2013.12.014_bib31","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2174\/157018007781788471","article-title":"Synthesis, biochemical evaluation and rationalisation of the inhibitory activity of a series of 4-substituted phenyl alkyl triazole-based compounds as potential inhibitors of 17\u03b1-hydroxylase\/17,20-Lyase (P45017\u03b1)","volume":"42","author":"Owen","year":"2007","journal-title":"Lett. Drug Design Discov."},{"key":"10.1016\/j.ejmech.2013.12.014_bib32","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1007\/s00044-011-9619-z","article-title":"Antinociceptive activities of some triazole and pyrazoline moieties-bearing compounds","volume":"21","author":"Ozkay","year":"2012","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2013.12.014_bib33","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2174\/1570193X11310010004","article-title":"Synthesis and biological applications of triazole derivatives \u2013 a review","volume":"10","author":"Kumar","year":"2013","journal-title":"J.\u00a0Mini-Rev. Org. Chem."},{"key":"10.1016\/j.ejmech.2013.12.014_bib34","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1007\/s00044-011-9902-z","article-title":"Synthesis and antidepressant activity of di substituted-5-aryl-1,2,4-triazoles","volume":"21","author":"Radhika","year":"2012","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2013.12.014_bib35","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11094-012-0764-6","article-title":"Computer analysis of the structure \u2013 antidepressant activity relationship in series of 1,2,4-triazole and thietane-1,1-dioxide derivatives","volume":"46","author":"Nikitina","year":"2012","journal-title":"Pharmaceut. Chem. J."},{"key":"10.1016\/j.ejmech.2013.12.014_bib36","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ejmech.2012.11.026","article-title":"Synthesis, characterization and preliminary anticonvulsant evaluation of some 4-alkyl-1,2,4-triazoles","volume":"60","author":"Plech","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.12.014_bib37","first-page":"265","article-title":"Synthesis of two novel 3-amino-5-[4-chloro-2-phenoxyphenyl]-4H-1,2,4-triazoles with anticonvulsant activity","volume":"9","author":"Mahdavi","year":"2010","journal-title":"Iran. J. Pharmaceut. Res."},{"key":"10.1016\/j.ejmech.2013.12.014_bib38","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1016\/j.bmcl.2005.07.051","article-title":"Synthesis and anticonvulsant activity of 7-alkoxyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolines","volume":"15","author":"Xie","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2013.12.014_bib39","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1248\/cpb.58.326","article-title":"Synthesis and anticonvulsant activity of some 7-alkoxy-2H-1,4-benzothiazin-3(4H)-ones and 7-alkoxy-4H-[1,2,4]triazolo[4,3-d]benzo[b][1,4]thiazines","volume":"58","author":"Zhang","year":"2010","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2013.12.014_bib40","doi-asserted-by":"crossref","first-page":"6775","DOI":"10.1016\/j.bmc.2007.08.004","article-title":"Synthesis and anticonvulsant evaluation of 4-(4-alkoxylphenyl)-3-ethyl-4 H-1,2,4-triazoles as open-chain analogues of 7-alkoxyl-4,5-dihydro[1,2,4]triazolo[4,3-a]quinolines","volume":"15","author":"Chen","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.12.014_bib41","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00044-009-9239-z","article-title":"Synthesis of 6-(3-substituted-4H-1,2,4-triazol-4-yl)-2-phenylbenzo[d]oxazoles as potential anticonvulsant agents","volume":"19","author":"Wei","year":"2010","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2013.12.014_bib42","first-page":"618","article-title":"Synthesisof 4,5-dihydro[1,2, 4]triazolo[4, 3-a]quinolinederivatives","volume":"5","author":"Zhang","year":"2002","journal-title":"Chem. Res. Appl."},{"key":"10.1016\/j.ejmech.2013.12.014_bib43","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1021\/ol048863a","article-title":"Efficient and regiospecific one-pot synthesis of substituted 1,2,4-triazoles","volume":"6","author":"Stocks","year":"2004","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2013.12.014_bib44","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.ejmech.2013.12.014_bib45","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1528-1157.1978.tb04507.x","article-title":"Antiepileptic drug development: II. Anticonvulsant drug screening","volume":"19","author":"Krall","year":"1978","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejmech.2013.12.014_bib46","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3949\/ccjm.51.2.293","article-title":"Antiepileptic drug development program","volume":"51","author":"Porter","year":"1984","journal-title":"Cleve. Clin. Q."},{"key":"10.1016\/j.ejmech.2013.12.014_bib47","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"St\u00e9ru","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejmech.2013.12.014_bib48","first-page":"306","article-title":"Comparative evaluation of Bacopa monniera and Panax quniquefolium in experimental anxiety and depressive models in mice","volume":"48","author":"Chatterjee","year":"2010","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.ejmech.2013.12.014_bib49","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0003-3472(73)80065-X","article-title":"Tests for emotionality in rats and mice: a review","volume":"21","author":"Archer","year":"1973","journal-title":"Anim. Behav."},{"key":"10.1016\/j.ejmech.2013.12.014_bib50","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"Cryan","year":"2002","journal-title":"Treads Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2013.12.014_bib51","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.neubiorev.2005.03.008","article-title":"Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejmech.2013.12.014_bib52","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.bbr.2005.06.015","article-title":"A\u00a0proposal of decision tree to screen putative antidepressants using forced swim and tail suspension tests","volume":"164","author":"Bourin","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejmech.2013.12.014_bib53","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00213-004-2048-7","article-title":"Forced swimming test in mice: a review of antidepressant activity","volume":"177","author":"Petit-Demouliere","year":"2005","journal-title":"Psychopharmacology (Berl.)"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523413008015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523413008015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T20:58:16Z","timestamp":1538945896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523413008015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":53,"alternative-id":["S0223523413008015"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2013.12.014","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and evaluation of the antidepressant and anticonvulsant activities of triazole-containing quinolinones","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2013.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}